Protagonist Therapeutics (PTGX) PT Raised to $121 at Jefferies

March 18, 2026 12:14 PM

Jefferies analyst Roger Song raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $121.00 (from $118.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found